Expression of pulmonary vascular angiotensin-converting enzyme in primary and secondary plexiform pulmonary hypertension

Journal of Pathology

Volumn 192, Issue 3, 2000, Pages 379-384

  Orte, Carlos ^a   Polak, Julia M ^a   Haworth, Sheila G ^b   Yacoub, Magdi H ^c   Morrell, Nicholas W ^a,d  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c HAREFIELD HOSPITAL   (United Kingdom)

^d HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Angiotensin converting enzyme; Pulmonary hypertension; Vascular remodelling

Indexed keywords

ANGIOTENSIN; CD31 ANTIGEN; DIPEPTIDYL CARBOXYPEPTIDASE; MONOCLONAL ANTIBODY;

ANTIGEN RETRIEVAL; ARTICLE; CAPILLARY ENDOTHELIUM; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG BLOOD VESSEL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULMONARY HYPERTENSION; QUANTITATIVE ASSAY; TISSUE SECTION;

ADULT; ANTIBODIES, MONOCLONAL; ANTIGENS, CD31; CASE-CONTROL STUDIES; HUMANS; HYPERTENSION, PULMONARY; LUNG; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; PULMONARY ARTERY;

EID: 0033645470     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/1096-9896(2000)9999:9999<::AID-PATH715>3.0.CO;2-Q     Document Type: Article

References (23)

1. Prevention of pulmonary vascular changes of chronic alveolar hypoxia by inhibition of angiotensin I-converting enzyme in the rat
2. Effects of SQ14.225, an orally active inhibitor of angiotensin-converting enzyme, on hypoxic pulmonary hypertension and right ventricular hypertrophy in rats
3. Angiotensin II receptor expression and inhibition in the chronically hypoxic rat lung
4. Pulmonary artery remodeling differs in hypoxia- and monocrotaline-induced pulmonary hypertension
5. Role of angiotensin converting enzyme and angiotensin II in development of hypoxic pulmonary hypertension
6. Angiotensin converting enzyme expression is increased in small pulmonary arteries of rats with hypoxia-induced pulmonary hypertension
7. Short- and long-term hemodynamic effects of captopril in patients with pulmonary hypertension and selected connective tissue disease
8. Persistent hemodynamic and clinical improvement after captopril in patients with pulmonary hypertension
9. The pathology of the early and late stages of primary pulmonary hypertension
10. Pulmonary artery adventitial changes and venous involvement in primary pulmonary hypertension
11. Primary pulmoary hypertension: Vascular structure, morphometry, and responsiveness to vasodilator agents
12. Histopathology of primary pulmonary hypertension. A qualitative and quantitative study of pulmonary blood vessels from 58 patients in the National Heart, Lung, and Blood Institute, Primary Pulmonary Hypertension Registry
13. 1 receptors
14. Angiotensin converting enzyme expression in primary pulmonary hypertension
15. The pathology of hypertensive pulmonary vascular disease
16. High expression of endothelial nitric oxide synthase in plexiform lesions of pulmonary hypertension
17. Immunohistochemical detection of hormone receptors in breast carcinomas (ER-ICA, PgR-ICA): Prognostic usefulness and comparison with the biochemical radioactive-ligand-binding assay (DCC)
18. The expression of angiotensin-I converting enzyme in human atherosclerotic plaques is not related to the deletion/insertion polymorphism but to the risk of restenosis after coronary interventions
19. Immunohistochemical study of angiotensin converting enzyme in human tissues using monoclonal antibodies
20. Effect of angiotensin II receptor blocker on angiotensin II stimulated DNA synthesis of cultured human aortic smooth muscle cells
21. Effect of angiotensin II on human vascular smooth muscle cell growth
22. Effects of angiotensin II and vasopressin on human smooth muscle cells in vitro
23. Captopril in primary pulmonary hypertension